Published in J Gastrointest Surg on August 07, 2013
Proton Pump Inhibitors: The Culprit for Barrett's Esophagus? Front Oncol (2015) 0.77
Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med (2013) 5.41
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet (2013) 4.48
Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin Chem (2005) 3.42
Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem (2004) 2.90
MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg (2007) 2.85
Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition. J Am Coll Surg (2004) 2.82
Endoscopic, deep mural implantation of Enteryx for the treatment of GERD: 6-month follow-up of a multicenter trial. Am J Gastroenterol (2003) 2.63
International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg (2015) 2.61
Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg (2003) 2.36
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res (2012) 2.26
Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells. Cell Stem Cell (2013) 2.23
Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett's esophagus: a randomized and blinded comparison. Am J Gastroenterol (2006) 2.07
Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies. Blood (2011) 1.91
Endoscopic implantation of enteryx for treatment of GERD: 12-month results of a prospective, multicenter trial. Am J Gastroenterol (2003) 1.84
Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Res (2008) 1.63
Enteryx implantation for GERD: expanded multicenter trial results and interim postapproval follow-up to 24 months. Gastrointest Endosc (2005) 1.62
Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis. J Thorac Oncol (2012) 1.61
Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer (2006) 1.49
Tests for finding complex patterns of differential expression in cancers: towards individualized medicine. BMC Bioinformatics (2004) 1.49
Esophageal function testing with combined multichannel intraluminal impedance and manometry: multicenter study in healthy volunteers. Clin Gastroenterol Hepatol (2003) 1.48
Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg (2006) 1.47
Eosinophilic esophagitis with severe GERD. Am J Gastroenterol (2009) 1.47
High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci U S A (2002) 1.46
Atypical variants of classic achalasia are common and currently under-recognized: a study of prevalence and clinical features. J Am Coll Surg (2011) 1.41
Bile exposure inhibits expression of squamous differentiation genes in human esophageal epithelial cells. Ann Surg (2012) 1.40
Physiologic basis for the treatment of epiphrenic diverticulum. Ann Surg (2002) 1.37
Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg (2004) 1.37
Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn (2007) 1.35
Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. Am J Gastroenterol (2002) 1.33
Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res (2004) 1.32
Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. Clin Chem (2007) 1.30
A new era in esophageal diagnostics: the image-based paradigm of high-resolution manometry. J Am Coll Surg (2009) 1.28
Pathogenesis of Barrett esophagus: deoxycholic acid up-regulates goblet-specific gene MUC2 in concert with CDX2 in human esophageal cells. Arch Surg (2007) 1.27
Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health. J Immunother (2005) 1.25
Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J Am Coll Surg (2010) 1.24
Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. Cancer Res (2005) 1.23
Endopolyploidy in irradiated p53-deficient tumour cell lines: persistence of cell division activity in giant cells expressing Aurora-B kinase. Cell Biol Int (2008) 1.22
Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma. Ann Thorac Surg (2012) 1.21
The pathogenesis of Barrett's esophagus: secondary bile acids upregulate intestinal differentiation factor CDX2 expression in esophageal cells. J Gastrointest Surg (2007) 1.21
Prognostic significance of micrometastasis in non-small-cell lung cancer. Clin Lung Cancer (2004) 1.20
Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. J Am Coll Surg (2013) 1.16
Esophageal perforation: surgical, endoscopic and medical management strategies. Curr Opin Gastroenterol (2010) 1.16
Hiatal hernia, lower esophageal sphincter incompetence, and effectiveness of Nissen fundoplication in the spectrum of gastroesophageal reflux disease. J Gastrointest Surg (2008) 1.15
Absence of gastroesophageal reflux disease in a majority of patients taking acid suppression medications after Nissen fundoplication. J Gastrointest Surg (2002) 1.13
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma. Neoplasia (2005) 1.12
MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. Ann Thorac Surg (2011) 1.10
Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway. Blood (2012) 1.09
The mutagenic potential of duodenoesophageal reflux. Ann Surg (2005) 1.08
Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas. Clin Cancer Res (2005) 1.06
Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. Clin Chem (2004) 1.06
En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus. Arch Surg (2004) 1.05
Preoperative lower esophageal sphincter pressure affects outcome of laparoscopic esophageal myotomy for achalasia. J Gastrointest Surg (2004) 1.02
HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma. Mod Pathol (2011) 1.01
A population-based analysis of emergent vs. elective hospital admissions for an intrathoracic stomach. Surg Endosc (2009) 0.99
Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome. J Gastrointest Surg (2007) 0.99
Surgical resection for locoregional esophageal cancer is underutilized in the United States. J Am Coll Surg (2010) 0.99
Esophageal stenting for malignant and benign disease: 133 cases on a thoracic surgical service. Ann Thorac Surg (2011) 0.98
Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. J Thorac Cardiovasc Surg (2003) 0.98
BMP-driven NRF2 activation in esophageal basal cell differentiation and eosinophilic esophagitis. J Clin Invest (2015) 0.96
A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer. Ann Surg (2006) 0.96
Barrett's esophagus in females: a comparative analysis of risk factors in females and males. Am J Gastroenterol (2005) 0.95
Perioperative risk of laparoscopic fundoplication: safer than previously reported-analysis of the American College of Surgeons National Surgical Quality Improvement Program 2005 to 2009. J Am Coll Surg (2012) 0.95
Early G₁ cyclin-dependent kinases as prognostic markers and potential therapeutic targets in esophageal adenocarcinoma. Clin Cancer Res (2011) 0.94
Comparison of the clinical and histological characteristics and survival of distal esophageal-gastroesophageal junction adenocarcinoma in patients with and without barrett mucosa. Arch Surg (2005) 0.94
Update on fundoplication for the treatment of GERD. Curr Gastroenterol Rep (2012) 0.93
Intraoperative qRT-PCR for detection of lymph node metastasis in head and neck cancer. Clin Cancer Res (2011) 0.93
Achalasia of the esophagus: a surgical disease. J Am Coll Surg (2008) 0.92
In human entrocytes, GLN transport and ASCT2 surface expression induced by short-term EGF are MAPK, PI3K, and Rho-dependent. Dig Dis Sci (2007) 0.91
A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients. Clin Cancer Res (2006) 0.91
Molecular determinants in targeted therapy for esophageal adenocarcinoma. Arch Surg (2006) 0.90
Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma. BMC Gastroenterol (2012) 0.90
Temperature-controlled primer limit for multiplexing of rapid, quantitative reverse transcription-PCR assays: application to intraoperative cancer diagnostics. Clin Chem (2002) 0.90
Gastrectomy as a remedial operation for failed fundoplication. J Gastrointest Surg (2007) 0.90
Vagal-sparing esophagectomy: a more physiologic alternative. Ann Surg (2002) 0.89
Association of kyphosis and spinal skeletal abnormalities with intrathoracic stomach: a link toward understanding its pathogenesis. J Am Coll Surg (2009) 0.89
The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. Ann Thorac Surg (2004) 0.89
Physiologic mechanism and preoperative prediction of new-onset dysphagia after laparoscopic Nissen fundoplication. J Gastrointest Surg (2002) 0.89
Bile acid alone, or in combination with acid, induces CDX2 expression through activation of the epidermal growth factor receptor (EGFR). J Gastrointest Surg (2008) 0.88
Does the value of PET-CT extend beyond pretreatment staging? An analysis of survival in surgical patients with esophageal cancer. J Gastrointest Surg (2009) 0.87
Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR. Ann Surg Oncol (2008) 0.87
Recent thymic emigrants and subsets of naive and memory T cells in the circulation of patients with head and neck cancer. Clin Immunol (2005) 0.87
Chemokine receptors 6 and 7 identify a metastatic expression pattern in squamous cell carcinoma of the head and neck. Adv Otorhinolaryngol (2005) 0.87
Molecular staging of lymph nodes from patients with esophageal adenocarcinoma. Clin Cancer Res (2005) 0.87
Should elective repair of intrathoracic stomach be encouraged? J Gastrointest Surg (2009) 0.87
Experimental evidence for mutagenic potential of duodenogastric juice on Barrett's esophagus. World J Surg (2003) 0.87
Improvement in educational effectiveness of morbidity and mortality conferences with structured presentation and analysis of complications. J Surg Educ (2010) 0.86
Properties of targeted preamplification in DNA and cDNA quantification. Expert Rev Mol Diagn (2015) 0.86
1E7-03, a low MW compound targeting host protein phosphatase-1, inhibits HIV-1 transcription. Br J Pharmacol (2014) 0.86
Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett's adenocarcinoma. J Gastrointest Surg (2004) 0.85
Pathogenesis of Barrett's esophagus: bile acids inhibit the Notch signaling pathway with induction of CDX2 gene expression in human esophageal cells. Surgery (2009) 0.85
Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited. Surgery (2013) 0.85